Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtronic launches stent delivery system in Canada

This article was originally published in Clinica

Executive Summary

Medtronic's Captivia delivery system is now available in Canada. The device delivers the Valiant thoracic stent graft, a minimally-invasive treatment for aneurysms and other lesions of the thoracic aorta. Captivia was approved by Health Canada on 3 August. The Minneapolis, Minnesota firm also CE marked the device for sale in Europe in October 2009 (, 9 October 2009). Both the Captivia system and the Valiant graft are investigational in the US, with their use limited to clinical trials.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts